Illumina Body Map 2 (GSE30611)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr18_+_31591869 Show fit | 5.99 |
ENST00000237014.8
|
transthyretin |
|
chr3_-_116445458 Show fit | 3.96 |
ENST00000490035.7
|
limbic system associated membrane protein |
|
chr5_-_11904417 Show fit | 3.50 |
ENST00000304623.13
|
catenin delta 2 |
|
chrX_-_13938618 Show fit | 3.22 |
ENST00000454189.6
|
glycoprotein M6B |
|
chr10_+_59176600 Show fit | 3.21 |
ENST00000373880.9
|
phytanoyl-CoA 2-hydroxylase interacting protein like |
|
chr1_-_173917281 Show fit | 3.01 |
ENST00000367698.4
|
serpin family C member 1 |
|
chr9_-_10612966 Show fit | 2.99 |
ENST00000381196.9
|
protein tyrosine phosphatase receptor type D |
|
chr11_+_107591077 Show fit | 2.67 |
ENST00000531234.5
ENST00000265840.12 |
ELMO domain containing 1 |
|
chr5_-_45696326 Show fit | 2.42 |
ENST00000673735.1
ENST00000303230.6 |
hyperpolarization activated cyclic nucleotide gated potassium channel 1 |
|
chr20_+_10218808 Show fit | 2.30 |
ENST00000254976.7
ENST00000304886.6 |
synaptosome associated protein 25 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 6.4 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.4 | 6.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 4.0 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 3.2 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.3 | 3.0 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 3.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 2.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 2.4 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.6 | 2.3 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.2 | 2.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 8.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 6.0 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 5.7 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 3.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 2.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 2.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.6 | 2.4 | GO:0098855 | HCN channel complex(GO:0098855) |
0.3 | 2.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.3 | 2.1 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 2.1 | GO:0031143 | pseudopodium(GO:0031143) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 7.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 6.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 3.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 3.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 3.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 2.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 2.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.7 | 2.2 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.2 | 2.2 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 2.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 9.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 3.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 1.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 1.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.8 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 5.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 3.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 3.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 2.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 2.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 2.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 2.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 2.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 1.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |